Science Current Events | Science News | Brightsurf.com
 

Cancer Cell Current Events | Cancer Cell News | 12
Page 12 of 149 | 3706 Results
Previous0708091011121314151617   Next   
Sort By: Page Views | Date
OHSU Cancer Institute researchers find novel chemo drug helps treat prostate cancer
Men with a certain type of prostate cancer have been shown to respond to a new chemotherapy drug, Sagopilone, plus prednisone in an international trial led by Oregon Health & Science University Cancer Institute researchers.   view more (2008-06-02)

PET imaging significantly enhances standard imaging in lung cancer staging
Positron emission tomography (PET) is a useful diagnostic tool that supports the need for more accurate staging of lung cancer and improved treatment for patients, concludes an extensive systematic review published online today in Journal of National Cancer Institute.   view more (2007-11-28)

Novel regulation of the common tumor suppressor PTEN
PTEN is one of the most commonly mutated tumor suppressor genes. It is an antagonist for many cellular growth, proliferation and survival processes. When mutated or deleted, it causes cancers of the prostate, breast, colon, and brain.   view more (2007-01-12)

Prostate Cancer Survival Benefit From A Combination Of Androgen Suppression And External Irradiation
Disease-free survival from advanced prostate cancer could be almost doubled if hormone-suppression therapy is used during and after radiotherapy for a duration of 3 years, suggest authors of an international study in this week's issue of THE LANCET. Long-term survival after radiotherapy for people... view more (2002-07-05)

Jefferson scientists identify protein key to breast cancer spread, potential new drug target
Researchers at the Kimmel Cancer Center at Jefferson have identified a protein that they say is key to helping a quarter of all breast cancers spread.   view more (2007-04-10)

Human Cytomegalovirus May Be Involved In Colorectal Cancer (p 1557)
Preliminary findings of a study in this week's issue of THE LANCET suggest that a common human virus may play a part in the cellular processes involved in the development of colorectal cancer. Colorectal cancer is the second most frequent cause of death from cancer in many developed countries;... view more (2002-11-13)

OHSU Discovery May Lead to Early Cancer Detection
OHSU pancreatic cancer expert Brett Sheppard, M.D., and colleagues in the OHSU Oregon Stem Cell Center, have developed antibodies that recognize pancreatic cancer; Sheppard is presenting these findings this week during Digestive Disease Week in San Diego.   view more (2008-05-23)

Light powered platinum more targeted & 80 times more powerful than similar cancer treatments
Researchers from the Universities of Warwick, Edinburgh, Dundee and the Czech Republic's Institute of Biophysics have discovered a new light-activated platinum-based compound that is up to 80 times more powerful than other platinum-based anti-cancer drugs and which can use "light... view more (2007-12-26)

Smoking During Adolescence Could Increase The Risk Of Breast Cancer (pp 1033, 1044)
Authors of a Canadian study in this week's issue of THE LANCET highlight the varying effects of smoking on the risk of breast cancer-adolescent women who smoke could be at an increased risk of breast cancer later in life compared with non-smokers. One in nine women in the UK have a lifetime risk of... view more (2002-10-02)

A new way to treat colon cancer?
Researchers at University of Utah's Huntsman Cancer Institute have discovered a new target for possible future colon cancer treatments - a molecule that is implicated in 85 percent of colon cancer cases.   view more (2006-10-10)

'Allergy cells' can aggravate cancer and psoriasis
The body's mast cells are mainly associated with allergic reaction in the way they release histamine and other inflammatory substances.   view more (2006-09-11)

Discovery of a mechanism that regulates cell movement
A study performed by researchers at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with researchers at the Instituto de Biología Molecular of the CSIC, reveal a mechanism that controls the movement of cells in a tissue by regulating cell adhesion.   view more (2008-07-21)

Tulane pioneers novel ovarian cancer treatment
The Tulane University Section of Hematology and Medical Oncology is investigating a novel treatment for ovarian cancer by using intravenous Ontak to deplete harmful cells that inhibit the body's natural immune response to fight cancer. Ovarian cancer is the fifth leading cancer killer of women in... view more (2005-07-18)

Researchers identify genes that allow brain cancer-causing stem cells to resist treatment
While great interest has followed the discovery of neural stem cells and their potential for someday treating diseases and injuries of the brain and spinal cord, recent research identified "cancer stem cells," a small population of cells that appear to be the source of cells comprising a... view more (2006-12-18)

T-beta-RIII joins the fight against breast cancer
Although the soluble factor TGF-beta has been shown to suppress the growth of tumor cells in the early stages of breast cancer, high levels of TGF-beta during the later stages of the disease are associated with a poor outcome.   view more (2006-12-08)

Massey researchers induce cell death in leukemia
Researchers from the Virginia Commonwealth University Massey Cancer Center today presented preclinical research at the American Association of Cancer Research's annual meeting suggesting the potential of a new combination treatment for chronic lymphocytic leukemia (CLL).   view more (2007-04-17)

UM researchers find new marker to identify cancer stem cells
Researchers at the University of Michigan Comprehensive Cancer Center have found a marker that can be used to identify stem cells in breast tumors, suggesting a potential simple test that could help determine the best treatment for breast cancer.   view more (2007-12-04)

Colorful spy tactics track live cells supporting cancerous tumors
A new advance in cellular imaging is allowing scientists to better understand the movement of cells in the area around tumors, also known as the tumor microenvironment.   view more (2008-09-17)

Standard treatment for prostate cancer may encourage spread of disease
A popular prostate cancer treatment called androgen deprivation therapy may encourage prostate cancer cells to produce a protein that makes them more likely to spread throughout the body, a new study by Johns Hopkins researchers suggests.   view more (2007-10-01)

Scripps research scientists show protein accelerates breast cancer progression in animal models
These new findings could lead to a better understanding of the molecular pathogenesis of breast cancer and focus attention on PTN and its signaling pathway as possible targets for new cancer therapies.   view more (2007-06-21)

Researchers first to map gene that regulates adult stem cell growth
A new discovery in stem cell research may mean big things for cancer patients in the future. Gary Van Zant, Ph.D., and a research team at the University of Kentucky published their findings today in Nature Genetics, an international scientific journal.   view more (2007-01-15)

Weizmann Institute scientists discover a control mechanism for metastasis
Metastasis - when cancer cells dissociate from the original tumor and migrate via the blood stream to colonize distant organs - is the main cause of cancer death.   view more (2007-08-08)

Women with AIDS face cervical cancer threat
According to a report issued last week by UNAIDS, access to antiretroviral therapy is beginning to reduce AIDS mortality worldwide.   view more (2007-12-03)

Research Europe 26 September issue: stories on cancer strategy, stem cell concessions, Cost control, aquaculture funding and Schröder`s victory
Commission plans cancer strategy The Commission is planning a European strategy on cancer research. This will include a list of common priorities for funding under Framework 6, the coordination of national research to avoid duplication and fragmentation, and a push for the harmonisation of... view more (2002-09-26)

Cancer therapy: A role for MAPK inhibitors combined with mTORC1 inhibitors
Nearly a decade ago, while it was being tested as an immunosuppressive agent to prevent organ rejection in transplant patients, the drug rapamycin was also discovered to have anti-tumor properties. Since then, several rapamycin analogs known as mTOR (mammalian target of rapamycin) inhibitors have... view more (2008-08-22)
Page 12 of 149 | 3706 Results
Previous0708091011121314151617   Next   
Sort By: Page Views | Date
© 2009 BrightSurf.com